Immuneering (IMRX) Accumulated Depreciation (2020 - 2022)

Immuneering's Accumulated Depreciation history runs 3 years deep, the most recent figure standing at $418337.0 for Q4 2022.

• In Q4 2022, Accumulated Depreciation rose 140.12% year-over-year to $418337.0; the TTM figure through Dec 2022 stood at $418337.0 (up 140.12% YoY), while the FY2022 annual figure was $418337.0, up 140.12% from the prior year.
• Accumulated Depreciation was $418337.0 for Q4 2022 at Immuneering, up from $344556.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $418337.0 in Q4 2022 to a low of $128752.0 in Q4 2020.
• Historically, Accumulated Depreciation has averaged $233887.4 across 3 years, with a median of $198071.0 in 2021.
• The sharpest annual moves came in 2021 and 2022: Accumulated Depreciation surged 35.31% in 2021, then soared 140.12% in 2022.
• A 3-year view of Accumulated Depreciation shows it stood at $128752.0 in 2020, then soared by 35.31% to $174219.0 in 2021, then jumped by 140.12% to $418337.0 in 2022.
• The last three Accumulated Depreciation figures came in at $418337.0 (Q4 2022), $344556.0 (Q3 2022), and $276482.0 (Q2 2022), per Business Quant data.